Blog
INNOBEX™: an in vitro model of the blood-brain barrier developed in house at Cellomatics
Over the years, several companies have designed different models to represent the blood-brain barrier (BBB) in vitro. These range from simple one cell type models
European expansion: meet Dr Pier Giorgio Amendola
Alongside its US expansion, Cellomatics is looking to consolidate its presence in Europe and has welcomed Dr Pier Giorgio Amendola to support with the company’s
Looking to the future: US expansion
The United States (US) is one of the biggest and most fast-growing biotech markets globally and Cellomatics is looking to further expand its client base
Posing (Neuro)inflammatory questions about dementia
To mark Parkinson’s Awareness Month our Senior Bioassay Scientist Dr Gareth Edwards delves into the role of neuroinflammation and its contribution to the global increase
Science Communication: Immune Cell Chemotaxis
In our first instalment of Science Communication our senior bioassay scientist delves into immune cell chemotaxis and the capabilities we have for this research at
Reflections on the year at Cellomatics Biosciences
With 2023 fast drawing to a close, we sat down with CEO and founder of Cellomatics Biosciences, Dr Shailendra Singh, to get his thoughts on
Request a consultation with Cellomatics Biosciences today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact a member of the team.
